ArticleCancer immunology research2022

Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment.

Dimitrios N Sidiropoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.